Open Access Open Access  Restricted Access Subscription or Fee Access

Clinical Utility of Black Tea Polyphenols in Chemoprevention and Therapeutics Against Cancer

Girish Rai, Ajeet Singh, Garima Srivastava

Abstract


Tea is the second-most preferred beverage produced from Camellia sinesis. It is cultivated in more than 30 countries. Several scientific studies have specified that polyphenolic compounds in tea may reduce the risk of a variety of infirmity including cancer. Most of the research evidences are available from green tea but limited information is available from black tea. Several studies have investigated both in vitro and in vivo models including rats, mice, and hamsters. Subsequently these results showed that tea consumption protects against lung, oesophagus, duodenum, pancreas, liver, breast, colon, and skin cancers. Other studies have also shown the preventive effect of black tea consumption against atherosclerosis and coronary heart disease, high blood cholesterol concentrations, and high blood pressure. Epidemiological studies and research findings in animal model have shown the chemopreventive potential of tea polyphenols in cancer but clinical utility of tea polyphenols have not been explored yet. From recent past, people are utilising some of the novel strategies to enhance anticancer efficacy of tea polyphenols. In the present study, we intensified that how researchers are utilising the advance pharmacology and pharmacodynamic approach to improve the chemopreventive as well as therapeutic value of tea polyphenols.


Keywords


Polyphenol, reactive oxygen species (ROS), catechins, 7,12-dimethylbenz[a]anthracene (DMBA), theaflavin (TF)

Full Text:

PDF

References


Weisburger JH. Mechanisms of action of antioxidants as exemplified in vegetables, tomatoes and tea. Food Chem Toxicol. 1999; 37(9–10): 943–948p.

Yang CS, et al. Cancer prevention by tea: Evidence from laboratory studies. Pharmacol Res. 2011; 64(2): 113–122p.

Katiyar S, Mukhtar H. Tea in chemoprevention of cancer. Int J Oncol. 1996; 8(2): 221–238p.

Dreosti IE, Wargovich MJ, Yang CS. Inhibition of carcinogenesis by tea: the evidence from experimental studies. Crit Rev Food Sci Nutr. 1997; 37(8): 761–770p.

Shukla Y. Tea and cancer chemoprevention: a comprehensive review. Asian Pac J Cancer Prev. 2007; 8(2): 155–166p.

Hansch GM, et al. The complement membrane attack complex stimulates the prostanoid production of cultured glomerular epithelial cells. Int Arch Allergy Appl Immunol. 1988; 85(1): 87–93p.

Kalra N, et al. Theaflavins induced apoptosis of LNCaP cells is mediated through induction of p53, down-regulation of NF-kappa B and mitogen-activated protein kinases pathways. Life Sci. 2007; 80(23): 2137–2146p.

Chung FL, et al. Inhibition of lung carcinogenesis by black tea in Fischer rats treated with a tobacco-specific carcinogen: caffeine as an important constituent. Cancer Res. 1998; 58(18): 4096–4101p.

Sil H, et al. Black tea polyphenol (theaflavin) downregulates MMP-2 in human melanoma cell line A375 by involving multiple regulatory molecules. J Environ Pathol Toxicol Oncol. 2010; 29(1): 55–68p.

Chang YC, et al. Black tea polyphenols reverse epithelial-to-mesenchymal transition and suppress cancer invasion and proteases in human oral cancer cells. J Agric Food Chem. 2012; 60(34): 8395–8403p.

Chen D, et al. Tea polyphenols, their biological effects and potential molecular targets. Histol Histopathol. 2008; 23(4): 487–496p.

Luo T, et al. (-)-Epigallocatechin gallate sensitizes breast cancer cells to paclitaxel in a murine model of breast carcinoma. Breast Cancer Res. 2010; 12(1): R8.

Tang SN, et al. EGCG enhances the therapeutic potential of gemcitabine and CP690550 by inhibiting STAT3 signaling pathway in human pancreatic cancer. PLoS One. 2012; 7(2): p. e31067.

Luczaj W, Skrzydlewska E. Antioxidative properties of black tea. Prev Med. 2005; 40(6): 910–918p.

Hayat K, et al. Tea and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2015; 55(7): 939–954p.

Price KR, Rhodes MJC, Barnes KA. Flavonol Glycoside Content and Composition of Tea Infusions Made from Commercially Available Teas and Tea Products. Journal of Agricultural and Food Chemistry. 1998; 46(7): 2517–2522p.

Chin JM, et al. Caffeine content of brewed teas. J Anal Toxicol. 2008; 32(8): 702–704p.

Henning SM, et al. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement. Am J Clin Nutr. 2004; 80(6): 1558–1564p.

Lambert JD, Yang CS. Mechanisms of cancer prevention by tea constituents. J Nutr. 2003; 133(10): 3262S–3267S.

Singh BN, et al. Black Tea: Phytochemicals, Cancer Chemoprevention and Clinical Studies. Crit Rev Food Sci Nutr. 2017; 57(7): 1394–1410p.

Steele VE, et al. Comparative chemopreventive mechanisms of green tea, black tea and selected polyphenol extracts measured by in vitro bioassays. Carcinogenesis. 2000; 21(1): 63–67p.

Matsuyama T, et al. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity (Silver Spring). 2008; 16(6): 1338–1348p.

Higdon JV, Frei B. Tea catechins and polyphenols: Health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 2003; 43(1): 89–143p.

Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr. 2006; 46(2): 101–123p.

Nawrot P, et al. Effects of caffeine on human health. Food Addit Contam. 2003; 20(1): 1–30p.

Krewski D, et al. Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide. J Toxicol Environ Health B Crit Rev. 2007; 10 Suppl 1: 1–269p.

Malik J, et al. Aluminium and other elements in selected herbal tea plant species and their infusions. Food Chem. 2013; 139(1–4): 728–734p.

Nelson M, Poulter J. Impact of tea drinking on iron status in the UK: A review. J Hum Nutr Diet. 2004; 17(1): 43–54p.

Gardner EJ, Ruxton CH, Leeds AR. Black tea—helpful or harmful? A review of the evidence. Eur J Clin Nutr. 2007; 61(1): 3–18p.

Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000; 100(1): 57–70p.

Pan MH, Ho CT. Chemo preventive effects of natural dietary compounds on cancer development. Chem Soc Rev. 2008; 37(11): 2558–2574p.

Dora I, et al. Black tea consumption and risk of rectal cancer in Moscow population. Ann Epidemiol. 2003; 13(6): 405–411p.

Baker JA, et al. Consumption of black tea or coffee and risk of ovarian cancer. Int J Gynecol Cancer. 2007; 17(1): 50–54p.

Kapiszewska M, et al. High tea consumption diminishes salivary 17beta-estradiol concentration in Polish women. Br J Nutr. 2006; 95(5): 989–995p.

Lee AH, et al. Tea consumption reduces ovarian cancer risk. Cancer Epidemiol. 2013; 37(1): 54–59p.

Wu S, et al. The association of tea consumption with bladder cancer risk: a meta-analysis. Asia Pac J Clin Nutr. 2013; 22(1): 128–137p.

Saha P, Das S. Elimination of Deleterious Effects of Free Radicals in Murine Skin Carcinogenesis by Black Tea Infusion, Theaflavins & Epigallocatechin Gallate. Asian Pac J Cancer Prev. 2002; 3(3): 225–230p.

Roy P, et al. Induction of apoptosis by tea polyphenols mediated through mitochondrial cell death pathway in mouse skin tumors. Cancer Biol Ther. 2009; 8(13): 1281–1287p.

George J, et al. Resveratrol and black tea polyphenol combination synergistically suppress mouse skin tumors growth by inhibition of activated MAPKs and p53. PLoS One. 2011; 6(8): e23395.

Roy P, et al. Inhibitory effects of tea polyphenols by targeting cyclooxygenase-2 through regulation of nuclear factor kappa B, Akt and p53 in rat mammary tumors. Invest New Drugs. 2011; 29(2): 225–231p.

Patel R, Ingle A, Maru GB. Polymeric black tea polyphenols inhibit 1,2-dimethylhydrazine induced colorectal carcinogenesis by inhibiting cell proliferation via Wnt/beta-catenin pathway. Toxicol Appl Pharmacol. 2008; 227(1): 136–146p.

Chen C, Kong AN. Dietary chemopreventive compounds and ARE/EpRE signaling. Free Radic Biol Med. 2004; 36(12): 1505–1516p.

Halder B, Das Gupta S, Gomes A. Black tea polyphenols induce human leukemic cell cycle arrest by inhibiting Akt signaling: Possible involvement of Hsp90, Wnt/beta-catenin signaling and FOXO1. FEBS J. 2012; 279(16): 2876–2891p.

Singh M, et al. Tea polyphenols induce apoptosis through mitochondrial pathway and by inhibiting nuclear factor-kappaB and Akt activation in human cervical cancer cells. Oncol Res. 2011; 19(6): 245–257p.

Singh M, et al. Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols. Invest New Drugs. 2010; 28(3): 216–224p.

Sharma H, Sen S, Singh N. Molecular pathways in the chemosensitization of cisplatin by quercetin in human head and neck cancer. Cancer Biol Ther. 2005; 4(9): 949–955p.

Youn MJ, et al. Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase-mediated pathway in HeLa cells. Biol Pharm Bull. 2008; 31(5): 789–795p.

Venkatraman M, et al. Biological and chemical inhibitors of NF-kappaB sensitize SiHa cells to cisplatin-induced apoptosis. Mol Carcinog. 2005; 44(1): 51–59p.

Buchholz TA, et al. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer. Clin Cancer Res. 2005; 11(23): 8398–8402p.

Biliran H Jr., et al. Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line. Clin Cancer Res. 2005; 11(16): 6075–6086p.

Zhou X, et al. Inhibition of cyclin D1 expression by cyclin D1 shRNAs in human oral squamous cell carcinoma cells is associated with increased cisplatin chemosensitivity. Int J Cancer. 2009; 124(2): 483–489p.

Singh M, et al. Tea polyphenols enhance cisplatin chemosensitivity in cervical cancer cells via induction of apoptosis. Life Sci. 2013; 93(1): 7–16p.




DOI: https://doi.org/10.37591/rrjols.v11i3.3201

Refbacks

  • There are currently no refbacks.